DNMT3A and cancer: In addition, no direct associations with AML have been reported so far for the 4 miRNAs (miR-153-2, miR-3065, miR-6718, miR-95) (Supplementary Table 4), but associations with other types of cancer suggest that differences in their expression between short- and long-lived DNMT3A-mutant AML patients could also be important for prognosis (see “Discussion”).